Psoriasis

Psoriasis is a common skin inflammation (irritation and swelling) characterized by frequent episodes of redness, itching, and thick, dry, silvery scales on the skin. It is not contagious and is suffered by 2-3% of the population. It might appear at any moment between 20 and 50. Eventhough its causes are unkown, there is a hereditary component and some triggering factors such as stress, traumatisms, infections (amigdalitis) and others such as certain medicines and alcohol.

There are multiple treatments. The most commonly used are topic ones such as queratolítics, coritcosteroids, vitamine D3 derivatives (e.g., tacalcitole, calcipotriole, calcitriole) and retinoides. Phototherapy is also widely used (PUVA, UVB) as well as sun baths. For more acute cases of psoriasis there are oral treatments such as inmunedepressors (e.g. ciclosporine), citostatics (e.g., metotrexate) and more recently, biological treatments, some of them still under study. It is very advisable to keep the skin correctly moistened both during the rash and non-rash phases. For more information, consult with your specialist.

Bonalfa

Medical prescription product.

Ureadin Rx®

Moisturising and specific care topic contributing treatment of psoriasic skin.

Germisdin Rx

Hygiene and specific care topic contributing treatment of psoriasic skin.

Related
documents
Products and
conditions
 
Posters, pappers and studies.
Epidemiological study of the use of phototherapy by dermatologists in Spain. The scan alfa study
17th EADV Paris
Treatment of scalp psoriasis with a non-coal tar shampoo: excellent cosmetic results with no loss of effectiveness
17th EADV Paris 2008
Deterioro de la función barrera de la piel como factor fisiopatológico en la psoriasis
Emolliency with a 20% urea & Ureadyl cream increases effectiveness of psoriasis therapy
21st World Congress of Dermatology Buenos Aires 2007
Is there a higher proportion of psoriasis among patients with onichomycosis?
21st World Congress of Dermatology Buenos Aires 2007
Análisis epidemiológico del uso de la fototerapia en España. Estudio Scan-Alfa
XXXV AEDV Granada 2007
La utilización de emolientes específicos muestra una relación intensa y significativa con la resolución de las lesiones psoriásicas
XXXV AEDV Granada 2007
Benefit of an adjuvant 20% urea & Ureadyl® cream in psoriatic patients with severe symptoms
16th EADV Vienna 2007
Effectiveness and safety of tacalcitol in the treatment of the psoriasis vulgaris: the alfa trial
16th EADV Vienna 2007
Noninvasive biophysiscal measurements to assets the evolution of psoriatic skin treated with tacalcitol ointment
65th AAD Washington 2007
Satisfaction and workload of the dermatologist according to its workplace in Spain Results of a psoriasis survery
15th EADV Rhodes 2006
Presión asistencial y burnout del dermatólogo en relación al paciente psoriásico
XXXIV AEDV Madrid 2006
Actitudes y tipología del paciente psoriásico: opinión de los dermatólogos
XXV RADLA Santiago de Chile 2006
Psoriasis treatment in Spain
XIV EADV London 2005
Encuesta sobre la psoriasis realizada a dermatólogos españoles
Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience
Estudio epidemiológico del tratamiento de la psoriasis en España
XXXIII AEDV Salamanca 2005
Browse all products

By condition

By brand name

By country

If you would like more information about our products, or can´t find what you are looking for, please contact us.